
ELV Stock Forecast & Price Target
ELV Analyst Ratings
Bulls say
Elevance Health is expected to continue its strong growth across its business lines, benefiting from its scale and unique position as the largest single provider of Blue Cross Blue Shield branded coverage. The company's solid financials and portfolio diversification make it an attractive investment, with potential for continued margin expansion and upside potential from its commercial and Medicare Advantage businesses. However, risks include potential volatility in the ACA market and Medicaid cost utilization spikes.
Bears say
Elevance Health is expected to face increased pressure in the commercial market and could be negatively impacted by adverse regulatory or legislative changes. The company also faces challenges in controlling medical costs, growing their government pay business, and expanding their third-party PBM business. Additionally, there are risks associated with potential deterioration in the risk pool in the ACA market, cost utilization spikes in Medicaid, and lack of growth in Carelon uptake. However, despite these challenges, Elevance Health's strong position as the largest Blue Cross Blue Shield provider and strategic acquisitions in the government-sponsored programs could lead to margin expansion opportunities in the future.
This aggregate rating is based on analysts' research of Elevance Health Inc and is not a guaranteed prediction by Public.com or investment advice.
ELV Analyst Forecast & Price Prediction
Start investing in ELV
Order type
Buy in
Order amount
Est. shares
0 shares